Related Experiment Videos

Sunscreen lotions prevent ultraviolet radiation-induced suppression of antitumor immune responses

L K Roberts1, D G Beasley

  • 1Department of Research and Development, Schering-Plough HealthCare Products, Memphis, TN 38151, USA. LEE.ROBERTS@SPCORP.COM

Insights

Sunscreen effectiveness in blocking UV radiation-induced immune suppression varies by UV source and dose. Sunscreens protect against tumor growth when tested under specific conditions, aligning with their labeled Sun Protection Factor (SPF).

Area of Science:

  • Immunology
  • Photobiology
  • Dermatology

Background:

  • Ultraviolet (UV) radiation exposure can suppress the immune system, promoting skin cancer development.
  • Sunscreens are known to prevent UV carcinogenesis, but their efficacy in blocking UV-induced immune suppression is debated.
  • Understanding the impact of UV spectrum and dose on sunscreen's immune protective capacity is crucial.

Purpose of the Study:

  • To evaluate how different UV spectra and doses affect the immune protective capacity of sunscreens.
  • To determine the relationship between labeled Sun Protection Factor (SPF) and actual tumor immune protection.
  • To assess the ability of sunscreens to block UV-induced activation of tumor antigen-specific suppressor T-lymphocytes.

Main Methods:

  • Four marketed sunscreen lotions with SPF 8-45 were tested.
  • Effective tumor immune suppression doses (TISD) were established for three different UV sources (unfiltered FS, Kodacel-filtered KFS, and solar simulator).
  • Tumor incidence, tumor growth rates, and T-lymphocyte activation were measured in UV-exposed mice with and without sunscreen application.

Main Results:

  • TISD varied significantly depending on the UV source, being lower for UVB-type sunlamps compared to a solar simulator.
  • Sunscreen's tumor immune protection correlated with its labeled SPF when tested under solar simulator conditions.
  • SPF 30 and 45 sunscreens blocked suppressor T-lymphocyte activation under solar simulator UV exposure.
  • Protection levels varied with UV source; sunscreens offered partial to complete protection against KFS UV but no measurable protection against FS UV.
  • All tested sunscreens reduced tumor growth rates in KFS UV-exposed mice.

Conclusions:

  • Sunscreen lotions offer tumor immune protection that is consistent with their labeled SPF, but only under specific testing conditions and UV spectra.
  • The UV spectrum and dose are critical factors determining sunscreen efficacy in preventing UV-induced immune suppression and subsequent tumor development.
  • Further research is needed to optimize sunscreen formulations and testing protocols to ensure comprehensive protection against UV-induced immune suppression.

Related Concept Videos